Umthong S, Timilsina U, D'Angelo MR, Salka K, Stavrou S. MARCH2, a T cell specific factor that restricts HIV-1 infection. PLoS Pathog. 2024 Jul 29;20(7):e1012330. doi: 10.1371/journal.ppat.1012330. PMID: 39074162; PMCID: PMC11309421.

Timilsina U, Ivey EB, Duffy S, Plianchaisuk A, The Genotype To Phenotype Japan G P-Japan Consortium, Ito J, Sato K, Stavrou S. SARS-CoV-2 ORF7a Mutation Found in BF.5 and BF.7 Sublineages Impacts Its Functions. Int J Mol Sci. 2024 Feb 16;25(4):2351. doi: 10.3390/ijms25042351. PMID: 38397027; PMCID: PMC10889720.

Timilsina U, Stavrou S. SERINC5: One antiviral factor to bind them all. PLoS Pathog. 2023 Jan 19;19(1):e1011076. doi: 10.1371/journal.ppat.1011076. PMID: 36656836; PMCID: PMC9851522.

Timilsina U, Umthong S, Ivey EB, Waxman B, Stavrou S. SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5. Nat Commun. 2022 May 26;13(1):2935. doi: 10.1038/s41467-022-30609-9. PMID: 35618710; PMCID: PMC9135752.

Umthong S, Lynch B, Timilsina U, Waxman B, Ivey EB, Stavrou S. Elucidating the Antiviral Mechanism of Different MARCH Factors. mBio. 2021 Mar 2;12(2):e03264-20. doi: 10.1128/mBio.03264-20. PMID: 33653895; PMCID: PMC8092282.

Timilsina U, Umthong S, Lynch B, Stablewski A, Stavrou S. SERINC5 Potently Restricts Retrovirus Infection In Vivo. mBio. 2020 Jul 14;11(4):e00588-20. doi: 10.1128/mBio.00588-20. PMID: 32665269; PMCID: PMC7360926.